topic:"Fluorodeoxyglucose F18 - diagnostic use" found 2 records - Provincial Hospitals Library Catalogue

Revise Search

Help

Narrow By

Print PDF

2 records – page 1 of 1.

FDG PET/CT in Clinical Oncology : Case Based Approach with Teaching Points

https://libcat.nshealth.ca/en/permalink/provcat31188

Jasna Mihailovic, Stanley J. Goldsmith, Ronan P. Killeen. --Berlin, Heidelberg: Springer , c2012.

Available Online: View e-Book

Location: Online

FDG PET/CT has rapidly emerged as an invaluable combined imaging modality that can identify tumors on the basis of not only anatomical alterations but also metabolic activity, thus allowing the detection of lesions that would otherwise be too small to distinguish. This book, comprising a collection of images from oncology cases, is organized according to the role of FDG PET/CT in the evaluation and management of oncology patients, and only secondarily by organ or tumor entity. In this way, it …

Available Online: View e-Book

Author: Mihailovic, Jasna

Other Authors: Goldsmith, Stanley J; Killeen, Ronan P

Responsibility: Jasna Mihailovic, Stanley J. Goldsmith, Ronan P. Killeen

Place of Publication: Berlin, Heidelberg

Publisher: Springer

Date of Publication: c2012

Physical Description: 1 online resource (xiv, 453 p. : 113 ill., 108 ill. in color)

ISBN: 9783642298660

Subjects (MeSH): Fluorodeoxyglucose F18 - diagnostic use; Neoplasms - diagnosis - Case Reports; Positron-Emission Tomography Computed Tomography - Atlases; Positron-Emission Tomography Computed Tomography - Case Reports

Subjects (LCSH): Radiology, Medical; Oncology; Diagnostic imaging

Abstract: FDG PET/CT has rapidly emerged as an invaluable combined imaging modality that can identify tumors on the basis of not only anatomical alterations but also metabolic activity, thus allowing the detection of lesions that would otherwise be too small to distinguish. This book, comprising a collection of images from oncology cases, is organized according to the role of FDG PET/CT in the evaluation and management of oncology patients, and only secondarily by organ or tumor entity. In this way, it reflects the issues that clinicians actually address in their daily practice, namely: identification of an unknown or unsuspected primary; determination of the extent of disease; evaluation of response to therapy; and surveillance after response, i.e., detection of recurrent disease. In total, 100 cases involving different primary tumors are presented to illustrate findings in these different circumstances. FDG PET/CT in Clinical Oncology will be of great value to all newcomers to this field, whether medical students, radiology, nuclear medicine, or oncology fellows, or practicing physicians.

Contents: Pt. I. DIAGNOSIS -- 1. Solitary pulmonary nodule (SPN), chest mass -- 2. Unknown primary -- 3. Unsuspected malignancy/second primary -- Pt. II. EXTENT OF DISEASE -- 4. Head and Neck Carcinoma -- 5. Lung Carcinoma -- 6. Breast Carcinoma -- 7. Esophageal Carcinoma -- 8. Colorectal Carcinoma -- 9. Lymphoma -- 10. Multiple Myeloma -- 11. Gynecological Adenocarcinomata -- 12. Miscellaneous Malignancies -- Pt III. FOLLOW UP -- 13. Head and Neck -- 14. Lung Carcinoma -- 15. Breast Carcinoma -- 16. Pancreas Carcinoma -- 17. Colorectal Carcinoma -- 18. Lymphoma -- 19. Multiple Myeloma -- 20. Thyroid Gland -- 21. Urologic Tumors Bladder -- 22. Miscellaneous -- Pt. IV. RESPONSE TO TREATMENT -- 23. Lymphoma -- 24. Multiple Mueloma -- 25. Lung -- 26. Gastrointestinal Tumors -- 27. Breast -- 28. Neuroendocrine Tumor -- Pt. V. NEURO SECTION -- 29. Brain Tumors.